Bryce Demoret DO

Physician

Summary

Bryce Demoret, DO, is a dermatology resident physician based in Largo, FL. He graduated Magna Cum Laude from The Ohio State University in 2018 with a B.S. in Biology and minors in Immunology and Business. Dr. Demoret earned his Doctor of Osteopathic Medicine degree from Ohio University Heritage College of Osteopathic Medicine in 2023, where he graduated at the top of his class and served as Class President.
He is the founder and president of Caps For A Cause, a nonprofit organization dedicated to increasing skin cancer awareness and prevention. Dr. Demoret completed his transitional year of internal medicine at HCA Florida Healthcare/USF Morsani College of Medicine in 2024 and is currently completing his three-year dermatology residency.
His research has been presented at national meetings and published in peer-reviewed journals, with a focus on cutaneous oncology, autoimmune disease, and liposarcoma. Dr. Demoret has received several accolades, including 1st Place in a Poster Competition from the Ohio Dermatological Association and the Sarcoma Central ‘Science Spotlight’ award from the American Society of Clinical Oncology.

HCA Florida Healthcare/USF Morsani College of Medicine GME - Tampa SouthResidency, Dermatology, 2024 - 2027
HCA Florida Healthcare/USF Morsani College of Medicine GME - Tampa SouthInternship, Transitional Year, 2023 - 2024
Ohio University Heritage College of Osteopathic Medicine in AthensClass of 2023
The Ohio State University BS, Biology, Magna Cum Laude, 2014 - 2018

1st Place Poster Competition Ohio Dermatologic Association, 2022
Sarcoma Central ‘Science Spotlight’ Winner American Society of Clinical Oncology, 2018

PubMed

Journal Articles

Prospective Evaluation of the Concordance of Commercial Circulating Tumor DNA Alterations with Tumor-Based Sequencing across Multiple Soft Tissue Sarcoma Subtypes
Demoret B, Jeffery G, Liebner DA, Gabriel A, Scott L, Chen JL, Cancers, 2019
MDM2 Dependent Rewiring of Metabolomic and Lipidomic Profiles in Dedifferentiated Liposarcoma Models
Patt A*, Demoret B*, Stets C, Bill KL, Smith P, Vijay A, Patterson A, Hays JL, Hoang M, Chen JL, Mathé EA, Cancers, 2020
Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcoma
Seligson N, Stets C, Demoret B, Awasthi A, Grosenbacher N, Shakya R, Hays JL, Chen JC, Oncotarget, 2019
Degree of MDM2 amplification affects clinical outcomes in dedifferentiated liposarcoma
Bill KL*, Seligson N*, Hays JL, Awasthi A, Demoret B, Stets C, Duggan MC, Bupathi M, Brock GN, Millis S, Shakya R, Timmers CD, Wakely PE, Pollock RE, Chen JL., The Oncologist, 2019
Loss of TXNIP enhances peritoneal metastasis and can be abrogated by dual TORC1/2 inhibition
Spaeth D, Burch M, Belton R, Demoret B, Grosenbacher N, David J, Stets C, Cohen D, Shakya R, Hays JL, Chen JC., Oncotarget, 2018
Join now to see all

Books/Book Chapters

Clinical Cases in Alopecia
Chapter: Discoid Lupus Erythematosis
Demoret B, Noll P, Sampath S, Trotter SCSpringer Nature2022
Clinical Cases in Alopecia
Chapter: Alopecia due to Nutritional Deficiency
Veon F, Demoret B, Sampath S, Trotter SCSpringer Nature2022

Abstracts/Posters

Acantholytic dyskeratosis of the vulva: A rare diagnosis clinically mimicking lichen sclerosus
Lauren Langenderfer, Bryce Demoret, Adam Hessel, Stephanie Fabbro, Ohio Dermatologic Association Annual Meeting
Pilot Study Evaluating The Concordance Of Circulating Tumor DNA Alterations With Tumor-based Sequencing In Soft Tissue Sarcoma
Bryce Demoret, Sherri Millis, Gabriel Tinoco, David Liebner, James L Chen, Connective Tissue Oncology Society Annual Meeting, Rome, Italy
Genomic amplification of CDK4 in dedifferentiated liposarcoma is a predictive biomarker for microtubule disrupting agents
Bryce Demoret, Andrew Rogers, Nathan Seligson, Esko Kautto, John L Hays, James L Chen, American Society of Clinical Oncology Annual Meeting, Chicago, IL, USA
Modulation of MDM2 in dedifferentiated liposarcomas sensitizes them to cholesterol directed therapy
Bryce Demoret, Colin Stets, Andrew Patt, John L Hays, Ewy Mathé, James L Chen, American Academy of Cancer Research Annual Meeting, Chicago, IL, USA
Modulation of MDM2 sensitizes dedifferentiated liposarcoma to cholesterol directed therapy
Bryce Demoret, Colin Stets, Andrew Patt, John L Hays, Ewy Mathé, James L Chen, Denman Undergraduate Research Forum
Join now to see all